The General Hospital Corporation;Trustees of Boston University;Massachusetts Institute of Technology;Whitehead Institute for Biomedical Research
发明人:
KOHANE, Daniel S.,RUBIN-BEJERANO, Ifat,FINK, Gerald R.,ABEIJON, Claudia,FULLER, Jason,LANGER, Robert
申请号：
AU2009243094
公开号：
AU2009243094B2
申请日:
2009.04.29
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The invention is directed to β 1-6 glucans, compositions, diagnostic kits, and devices comprising the same, and methods of use thereof in modulating immune response and treating, delaying progression of, reducing the incidence or severity of cancer, infection, inflammation, and autoimmune diseases. The β 1-6 glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety. The β 1-6 glucans of certain embodiments of the invention recruit immunoglobulin G antibodies to mediate complement and neutrophil killing. The conjugated β 1-6 glucans of certain embodiments of the invention are targeted to cells to stimulate the immune response at the target location by activating complement-mediated lysis and recruitment of neutrophils.
